Dr. Polite is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-834-3834
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2003 - 2006
- University of ChicagoResidency, Internal Medicine, 2000 - 2003
- Indiana University School of MedicineClass of 2000
- Goucher CollegeNon Degree, 1995 - 1996
- University of ChicagoM.P.P., 1990 - 1992
- University of ChicagoA.B., Public Policy Studies, With General Honors, 1987 - 1991
Certifications & Licensure
- IL State Medical License 2000 - 2026
- IN State Medical License 2023 - 2025
Awards, Honors, & Recognition
- Distinguished Clinician Award University of Chicago, 2015
- Hematology Oncology Fellow Teaching Award University of Chicago, 2014
- Nominated Candidate for ASCO Board of Directors 2014-2015
- Join now to see all
Clinical Trials
- A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients Start of enrollment: 2009 Dec 12
- Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials Start of enrollment: 2013 Nov 26
Publications & Presentations
PubMed
- 408 citationsEffect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trialJulio Garcia-Aguilar, Oliver S. Chow, David D. Smith, Jorge E. Marcet, Peter A. Cataldo
The Lancet. Oncology. 2015-08-01 - 5 citationsEarly Integrated Palliative Care Within a Surgical Oncology Clinic.Varun V Bansal, Daniel Kim, Biren Reddy, Hunter D D Witmer, Ankit Dhiman
JAMA Network Open. 2023-11-01 - 604 citationsEffect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: ...Alan P. Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Briant Fruth
JAMA. 2017-06-20
Journal Articles
- Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the Ame...Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Pask..., J Clin Oncol, 1/24/2017
- Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the Ame...Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Pask..., CA Cancer J Clin, 1/24/2017
- Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the Ame...Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Pask..., Cancer Res, 1/24/2017
- Join now to see all
Books/Book Chapters
Lectures
- Challenges to Access in the United StatesASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- What to Expect From Washington, DC in 2018-20192018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- The OCM Journey: One Practice's Experience-Warts and All.Orlando, FL - 1/1/2017
- Join now to see all
Other
- Reducing Disparities in Cancer Outcomes: A Call to Action.Polite BN, ASCO Daily News
Chicago - 1/3/2011 - American Society of Clinical Oncology Position Statement On Addressing the Affordability of Cancer Drugs.Polite BN, et. Al
https://www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/documents/2017-ASCO-Position-Statement-Affordability-Cancer-Drugs.pdf
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: